Prognostic Significance of Ki67 Index after Neoadjuvant Chemotherapy for Human Breast Cancer

被引:0
|
作者
Tanei, T. [1 ]
Shimomura, A. [1 ]
Shimazu, K. [1 ]
Nakayama, T. [1 ]
Kim, S. J. [1 ]
Tamaki, Y. [1 ]
Noguchi, S. [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
关键词
D O I
10.1158/0008-5472.SABCS10-P1-11-19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-11-19
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
    Tanei, T.
    Shimomura, A.
    Shimazu, K.
    Nakayama, T.
    Kim, S. J.
    Iwamoto, T.
    Tamaki, Y.
    Noguchi, S.
    EJSO, 2011, 37 (02): : 155 - 161
  • [2] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Jones, Robin L.
    Salter, Janine
    A'Hern, Roger
    Nerurkar, Ash
    Parton, Marina
    Reis-Filho, Jorge S.
    Smith, Ian E.
    Dowsett, Mitchell
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 53 - 68
  • [3] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Robin L. Jones
    Janine Salter
    Roger A’Hern
    Ash Nerurkar
    Marina Parton
    Jorge S. Reis-Filho
    Ian E. Smith
    Mitchell Dowsett
    Breast Cancer Research and Treatment, 2009, 116 : 53 - 68
  • [4] Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer
    Yoshioka, Tatsuya
    Hosoda, Mitsuchika
    Yamamoto, Mitsugu
    Taguchi, Kazunori
    Hatanaka, Kanako C.
    Takakuwa, Emi
    Hatanaka, Yutaka
    Matsuno, Yoshihiro
    Yamashita, Hiroko
    BREAST CANCER, 2015, 22 (02) : 185 - 191
  • [5] Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer
    Tatsuya Yoshioka
    Mitsuchika Hosoda
    Mitsugu Yamamoto
    Kazunori Taguchi
    Kanako C. Hatanaka
    Emi Takakuwa
    Yutaka Hatanaka
    Yoshihiro Matsuno
    Hiroko Yamashita
    Breast Cancer, 2015, 22 : 185 - 191
  • [6] Prognostic (Px) significance of Ki67 before and after neoadjuvant chemotherapy (CT) in early breast cancer
    Jones, R. L.
    Salter, J.
    Nerurkar, A.
    Parton, M.
    A'Hern, R.
    Smith, I. E.
    Dowsett, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
    von Minckwitz, Gunter
    Schmitt, Wolfgang D.
    Loibl, Sibylle
    Mueller, Berit M.
    Blohmer, Jens U.
    Sinn, Bruno V.
    Eidtmann, Holger
    Eiermann, Wolfgang
    Gerber, Bernd
    Tesch, Hans
    Hilfrich, Joern
    Huober, Jens
    Fehm, Tanja
    Barinoff, Jana
    Ruediger, Thomas
    Erbstoesser, Erhard
    Fasching, Peter A.
    Karn, Thomas
    Mueller, Volkmar
    Jackisch, Christian
    Denkert, Carsten
    CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4521 - 4531
  • [8] Prognostic significance of Ki67 during neoadjuvant chemotherapy in primary unresectable ovarian cancer
    Kaya, Ryusuke
    Takanashi, Hiroko
    Nakajima, Akari
    Saito, Ryosuke
    Yamaguchi, Noriko
    Morimoto, Keiji
    Isonishi, Seiji
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (11) : 3979 - 3989
  • [9] Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy
    Tan, Qi-Xing
    Qin, Qing-Hong
    Yang, Wei-Ping
    Mo, Qin-Guo
    Wei, Chang-Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6862 - 6870
  • [10] Prognostic Significance of the Ki67 Scoring Categories in Breast Cancer Subgroups
    Niikura, Naoki
    Masuda, Shinobu
    Kumaki, Nobue
    Tang Xiaoyan
    Terada, Mizuho
    Terao, Mayako
    Iwamoto, Takayuki
    Oshitanai, Risa
    Morioka, Toru
    Tuda, Banri
    Okamura, Takuho
    Saito, Yuki
    Suzuki, Yasuhiro
    Tokuda, Yutaka
    CLINICAL BREAST CANCER, 2014, 14 (05) : 323 - 329